These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33762369)

  • 1. Controversies in revascularisation for stable coronary artery disease.
    Nowbar AN; Rajkumar C; Al-Lamee RK; Francis DP
    Clin Med (Lond); 2021 Mar; 21(2):114-118. PubMed ID: 33762369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimising physiological endpoints of percutaneous coronary intervention.
    Al-Lamee R; Rajkumar CA; Ganesananthan S; Jeremias A
    EuroIntervention; 2021 Apr; 16(18):e1470-e1483. PubMed ID: 33792544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
    Weisz G; Généreux P; Iñiguez A; Zurakowski A; Shechter M; Alexander KP; Dressler O; Osmukhina A; James S; Ohman EM; Ben-Yehuda O; Farzaneh-Far R; Stone GW;
    Lancet; 2016 Jan; 387(10014):136-45. PubMed ID: 26474810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a comprehensive cardiac rehabilitation programme versus coronary revascularisation in patients with stable angina pectoris: study protocol for the PRO-FIT randomised controlled trial.
    Heutinck JM; De Koning IA; Vromen T; Van Geuns RM; Thijssen DHJ; Kemps HMC;
    BMC Cardiovasc Disord; 2023 May; 23(1):238. PubMed ID: 37147562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COURAGE, ORBITA, and ISCHEMIA: Percutaneous Coronary Intervention for Stable Coronary Artery Disease.
    Teoh Z; Al-Lamee RK
    Interv Cardiol Clin; 2020 Oct; 9(4):469-482. PubMed ID: 32921371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of revascularisation in stable coronary artery disease without ischaemia: a Danish registry-based follow-up study.
    Simonsen JA; Mickley H; Johansen A; Hess S; Thomassen A; Gerke O; Jensen LO; Hallas J; Vach W; Hoilund-Carlsen PF
    BMJ Open; 2017 Aug; 7(8):e016169. PubMed ID: 28801416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
    Mäkikallio T; Holm NR; Lindsay M; Spence MS; Erglis A; Menown IB; Trovik T; Eskola M; Romppanen H; Kellerth T; Ravkilde J; Jensen LO; Kalinauskas G; Linder RB; Pentikainen M; Hervold A; Banning A; Zaman A; Cotton J; Eriksen E; Margus S; Sørensen HT; Nielsen PH; Niemelä M; Kervinen K; Lassen JF; Maeng M; Oldroyd K; Berg G; Walsh SJ; Hanratty CG; Kumsars I; Stradins P; Steigen TK; Fröbert O; Graham AN; Endresen PC; Corbascio M; Kajander O; Trivedi U; Hartikainen J; Anttila V; Hildick-Smith D; Thuesen L; Christiansen EH;
    Lancet; 2016 Dec; 388(10061):2743-2752. PubMed ID: 27810312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery.
    Aziz O; Rao C; Panesar SS; Jones C; Morris S; Darzi A; Athanasiou T
    BMJ; 2007 Mar; 334(7594):617. PubMed ID: 17337458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction in China: Results From the China PEACE Prospective Study of Percutaneous Coronary Intervention.
    Lu Y; Zhang H; Wang Y; Zhou T; Welsh J; Liu J; Guan W; Li J; Li X; Zheng X; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
    JAMA Netw Open; 2018 Dec; 1(8):e185446. PubMed ID: 30646292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta blockers versus calcium channel blockers for provocation of vasospastic angina after drug-eluting stent implantation: a multicentre prospective randomised trial.
    Sawano M; Katsuki T; Kitai T; Tamita K; Obunai K; Ikegami Y; Yamane T; Ueda I; Endo A; Maekawa Y; Kawamura A; Fukuda K; Kohsaka S
    Open Heart; 2020 Oct; 7(2):. PubMed ID: 33087441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography-Stratified Analysis of ORBITA.
    Al-Lamee RK; Shun-Shin MJ; Howard JP; Nowbar AN; Rajkumar C; Thompson D; Sen S; Nijjer S; Petraco R; Davies J; Keeble T; Tang K; Malik I; Bual N; Cook C; Ahmad Y; Seligman H; Sharp ASP; Gerber R; Talwar S; Assomull R; Cole G; Keenan NG; Kanaganayagam G; Sehmi J; Wensel R; Harrell FE; Mayet J; Thom S; Davies JE; Francis DP
    Circulation; 2019 Dec; 140(24):1971-1980. PubMed ID: 31707827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Benefit of elective percutaneous coronary intervention for stable coronary artery disease].
    Ennezat PV; Malergue MC; Czitrom D; Maréchaux S; Tricot O; Le Jemtel TH; Vincentelli A
    Presse Med; 2019 Oct; 48(10):1037-1042. PubMed ID: 31676217
    [No Abstract]   [Full Text] [Related]  

  • 13. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
    Sabatine MS; Bergmark BA; Murphy SA; O'Gara PT; Smith PK; Serruys PW; Kappetein AP; Park SJ; Park DW; Christiansen EH; Holm NR; Nielsen PH; Stone GW; Sabik JF; Braunwald E
    Lancet; 2021 Dec; 398(10318):2247-2257. PubMed ID: 34793745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
    Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR
    Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus.
    Grodzinsky A; Kosiborod M; Tang F; Jones PG; McGuire DK; Spertus JA; Beltrame JF; Jang JS; Goyal A; Butala NM; Yeh RW; Arnold SV
    Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28904076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Techniques and approaches for revascularisation of left heart coronary diseases.
    Maskell P; Oo S; Muir AD; Fan KS; Harky A
    Br J Hosp Med (Lond); 2020 Aug; 81(8):1-11. PubMed ID: 32845756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Angina Post Percutaneous Coronary Intervention.
    Cruz Rodriguez JB; Kar S
    Curr Cardiol Rep; 2020 Jan; 22(2):7. PubMed ID: 31965355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial revascularisation in renal dysfunction: a systematic review and meta-analysis.
    Deo SV; Shah IK; Dunlay SM; Erwin PJ; Dillon JM; Park SJ
    Heart Lung Circ; 2013 Oct; 22(10):827-35. PubMed ID: 23548338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding.
    Nowbar AN; Francis DP; Al-Lamee RK
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):1011-1018. PubMed ID: 34417901
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.